✦ LIBER ✦

O65 HIGH RATE OF SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH HCV GENOTYPE-1A INFECTION: A PHASE 2 TRIAL OF FALDAPREVIR, DELEOBUVIR AND PPI-668, WITH AND WITHOUT RIBAVIRIN

✍ Scribed by Lalezari, J.; Holland, L.; Glutzer, E.; Vig, P.; Elgadi, M.; Stern, J.O.; Colonno, R.; Halfon, S.; Ruby, E.; Huang, N.; Nash, E.; Brown, N.

Book ID: 123278355
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 98 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60067-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

828 TREATMENT WITH PEGINTERFERON ALFA-2A

828 TREATMENT WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN OLDER HCV GENOTYPE 1 PATIENTS WITH POSITIVE PROGNOSTIC FACTORS LEADS TO HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE

✍ K.R. Reddy; D. Messinger; M. Popescu; S.J. Hadziyannis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

[613] VIROLOGICAL RESPONSE AT 4 AND 12 W

[613] VIROLOGICAL RESPONSE AT 4 AND 12 WEEKS PREDICT HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN GENOTYPE 1 PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) PLUS RIBAVIRIN

✍ P. Marcellin; S.J. Hadziyannis; T. Berg; J.M. Sanchez-Tapias; J.-P. Bronowicki; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 259 KB

2005 VIROLOGIC RESPONSE RATES FOLLOWING

2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS

✍ Jacobson, I.; Pockros, P.J.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJ 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

P1157 IMPACT OF BASELINE VARIABLES ON RE

P1157 IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL

✍ Tural, C.; Rockstroh, J.K.; Nelson, M.; Bhagani, S.; Ingiliz, P.; Soriano, V.; N 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS

✍ Marcellin, P.; Cooper, C.; Balart, L.A.; Larrey, D.G.; Box, T.D.; Yoshida, E.; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB